Abstract
Metabolic syndrome (MS) is a constellation of morbidities comprising dysglycemia, high blood pressure, atherogenic dyslipidemia, and obesity (especially abdominal). This clinical condition increases the risk of developing cardiovascular disease (CVD) and/or diabetes mellitus (DM). Obese individuals present an inflammatory infiltrate among adipocytes from their abdominal adipose tissue. Th…